Literature DB >> 142845

A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation.

G P Murphy, R P Gibbons, D E Johnson, S A Loening, G R Prout, J D Schmidt, D S Bross, T M Chu, J F Gaeta, J Saroff, W W Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 142845     DOI： 10.1016/s0022-5347(17)57975-6

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  4 in total

1.  Effect of estramustine phosphate (Estracyt) on transplantable mouse tumours.

Authors:  M Wakisaka; I Iwasaki; J Shimazaki
Journal:  Urol Res       Date:  1979-12

Review 2.  Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.

Authors:  C M Perry; D McTavish
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

Review 3.  Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.

Authors:  I Könyves
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

Review 4.  Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group.

Authors:  Eric Winquist; Tricia Waldron; Scott Berry; D Scott Ernst; Sébastien Hotte; Himu Lukka
Journal:  BMC Cancer       Date:  2006-05-02       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.